tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Atara Biotherapeutics reports Q3 EPS (32c), consensus (67c)

Reports Q3 revenue $3.45M, consensus $2.74M. The company said, “As previously communicated, Atara continues to actively explore and assess potential strategic alternatives with the goal of maximizing shareholder value.”

Claim 50% Off TipRanks Premium and Invest with Confidence

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1